AstraZeneca EU supply chain shortfall continues in second quarter

Ahead of the EU's approval of the vaccine at the end of January, the British-Swedish company sparked fury among European leaders by announcing that it would miss its target of supplying the EU with 400 million doses, due to a shortfall at the firm's European plants

from mint - News https://ift.tt/3dKbepR
https://ift.tt/eA8V8J